Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.056 AUD | -6.67% | 0.00% | +12.00% |
May. 23 | Firebrick Pharma Obtains Nasodine Composition Patent in South Africa | MT |
May. 17 | Firebrick Pharma Raises AU$800,000 via Placement | MT |
Sales 2022 | 1.08M 722K | Sales 2023 | 22.55K 15.04K | Capitalization | 27.32M 18.22M |
---|---|---|---|---|---|
Net income 2022 | -3M -2M | Net income 2023 | -6M -4M | EV / Sales 2022 | 34.7 x |
Net cash position 2022 | 7.15M 4.77M | Net cash position 2023 | 2.35M 1.57M | EV / Sales 2023 | 1,107 x |
P/E ratio 2022 |
-8.13
x | P/E ratio 2023 |
-3.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.95% |
1 day | -6.67% | ||
Current month | -6.67% | ||
1 month | -25.33% | ||
3 months | +12.00% | ||
6 months | -9.68% | ||
Current year | +12.00% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Goodall
FOU | Founder | - | 12-04-11 |
Chief Executive Officer | 70 | 12-04-11 | |
Kavi Bekarma
DFI | Director of Finance/CFO | - | 23-01-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Gardner
BRD | Director/Board Member | 73 | 20-11-12 |
Richard Treagus
BRD | Director/Board Member | 58 | 22-05-31 |
Chief Executive Officer | 70 | 12-04-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 0.056 | -6.67% | 112,142 |
24-06-05 | 0.06 | 0.00% | 20,000 |
24-06-04 | 0.06 | 0.00% | 182,959 |
24-06-03 | 0.06 | 0.00% | 194,578 |
24-05-31 | 0.06 | +7.14% | 25,004 |
Delayed Quote Australian S.E., June 06, 2024 at 01:30 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.00% | 7.78M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- FRE Stock